REED ELIZABETH E 4

4 · Travere Therapeutics, Inc. · Filed Feb 3, 2026

AI-generated summary of this filing

Updated Feb 4, 2026

Travere Therapeutics (TVTX) CLO Elizabeth Reed Sells Shares

What Happened

Elizabeth E. Reed, Chief Legal Officer & General Counsel of Travere Therapeutics (TVTX), reported a sale and awards. On 2026-02-03 Reed disposed of 7,175 shares in an open-market sale at $32.12 each, netting $230,461. On 2026-01-31 she received two awards: 25,110 shares (RSUs) and 66,960 derivative RSUs (both reported with $0 purchase price as awards).

Key Details

Transaction dates and prices:
- 2026-02-03: Sale of 7,175 shares at $32.12 — proceeds $230,461 (code S).
- 2026-01-31: Grant/award of 25,110 RSUs (code A) and 66,960 derivative RSUs (code A), reported at $0.
Shares owned after transaction: Not specified in the provided filing.
Notable footnotes:
- F1: Each restricted stock unit (RSU) represents a contingent right to one share of common stock.
- F2: The 7,175-share sale represents a required "sell-to-cover" to satisfy tax withholding on vested RSUs — it was mandated by the issuer and not a discretionary trade by the reporting person.
- F3: Describes a standard stock-option vesting schedule (one-fourth after one year, then monthly over 36 months) — included in the filing as grant/award terms.
Filing timeliness: Report filed 2026-02-03 for transactions dated 2026-01-31 and 2026-02-03; no indication in the filing that it was late.

Context

The sale appears to be a routine sell-to-cover tied to RSU settlement (per F2), which is a common administrative step and not necessarily a signal about the officer’s view of the stock. The newly granted RSUs are contingent rights that will convert to shares as they vest. The derivative RSU award is not an exercised option — it’s an award that may convert to shares per the plan’s vesting terms.

Form 4

Period: 2026-01-31

Chief Legal Officer and GC

Transactions

Sale
Common Stock
[F2]
2026-02-03$32.12/sh−7,175$230,461→ 108,205 total
Award
Common Stock
[F1]
2026-01-31+25,110→ 115,380 total
Award
Employee stock option (right to buy)
[F3]
2026-01-31+66,960→ 66,960 total
Exercise: $33.09Exp: 2036-01-31→ Common Stock (66,960 underlying)

Footnotes (3)

[F1]Each restricted stock unit represents a contingent right to receive one share of the Common Stock of the Issuer.
[F2]Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the settlement of vested restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person.
[F3]One-fourth of the shares subject to the stock option vest and become exercisable on the first anniversary of the date of grant, and the remaining shares vest in 36 equal monthly installments thereafter.

Signature

/s/ Elizabeth E. Reed|2026-02-03

1 file